Excellence engineered.

Home Ürünlerimiz CRT devices GALI SONR

Longest lasting CRT-D1.

✔ Up to 11 years of longevity.2

✔ Automatic & hemodynamic CRT optimization.3

✔ Lowest rate of inappropriate shocks.4

✔ Empower AF Risk Management.5



Outstanding Longevity.

Gali SonR™ incorporates advanced technology that withstands the test of time.

With the lowest current drain and a large battery capacity, MicroPort™ CRM excels in predicted longevity with up to 5 more years compared to other devices1, protecting patients from early replacements and associated complications.

Getty Images 1071375790


Translating the natural beat into engineering excellence.

Physio-inspired design.
Mimics the natural way the heart works and minimizes artificial intervention.

Wave to wave thinking.
A permanent adaptive strategy for real-time decisions that respond to all levels of patient activity, day and night, evolving and learning with the patient.

Symbiotic Programming.
Programming is driven only by hemodynamic needs. All therapeutic features are independently programmable, designed to work together simultaneously with no conflict.

Getty Images 946662324


Helping you manage…
…what can’t be seen.

Atrial prematurity detection: Detect AF with 96% sensitivity and 96% specificity5

Long cycle search criteria: Protect patients from risks associated with AF6

Getty Images 540547862


Optimizing patient outcomes, while saving time and resources.

MicroPort™ CRM understands the value of time for medical professionals. For this reason, we provide clinically proven high-end features3,7 in our long-lasting devices1, for optimizing patient outcomes, while saving time and resources avoiding unscheduled visits, hospitalization and unnecessary interventions.

Getty Images 840514476
  1. Competition comparison made as of March 2020, refer to manufacturers manuals and Boston Scientific longevity calculator available online. Applicable conditions: A, V=2.5V; 0.4ms; 500ohms; 100% (15% A pacing for Medtronic Cobalt/Crome); VVI for VR models / DDD for DR models; 60 bpm (40bpm for Biotronik Acticor 7 VR-T, Rivacor 3/5/7 VR-T); Sensor ON (OFF for Abbott Gallant, Biotronik Acticor 7, Rivacor 3/5/7, Medtronic Cobalt/Crome); Remote ON; RF telemetry 45min-2h at implant and 15-60 min p.a.; 2 battery charges p.a. for capacitor maintenance (1 every 9 months + 4 at implant for Gallant).
  2. Munawar DA, Mahajan R, Linz D, Wong GR, Khokhar KB, Thiyagarajah A, Kadhim K, Emami M, Mishima R, Elliott AD, Middeldorp ME, Roberts-Thompson KC, Young GD, Sanders P, Lau DH. Predicted longevity of contemporary cardiac implantable electronic devices: A call for industry-wide "standardized" reporting. Heart Rhythm. 2018 Dec;15(12):1756-1763.
  3. Lunati M, Magenta G, Cattafi G, Moreo A, Falaschi G, Contardi D, Locati E. Clinical Relevance Of Systematic CRT Device Optimization. J Atr Fibrillation. 2014 Aug 31;7(2):1077.
  4. Ruiz-Granell R, Dovellini EV, Dompnier A, Khalighi K, García-Campo E, Olivier A, Barcelo A, Ritter P. Algorithm-based reduction of inappropriate defibrillator shock: Results of the Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination-Implantable Cardioverter Defibrillator Study. Heart Rhythm. 2019 Sep;16(9):1429-1435.
  5. Géroux L, et al. Clinical performances of a new mode switch function based on a statistical analysis of the atrial rhythm. Herzschr Elektrophys. 1999; 10(Suppl 1):S15-S21.
  6. Hintringer F, Deibl M, Berger T, Pachinger O, Roithinger FX. Comparison of the specificity of implantable dual chamber defibrillator detection algorithms. Pacing Clin Electrophysiol. 2004 Jul;27(7):976-82.
  7. Brugada J, Delnoy PP, Brachmann J, Reynolds D, Padeletti L, Noelker G, Kantipudi C, Rubin Lopez JM, Dichtl W, Borri-Brunetto A, Verhees L, Ritter P, Singh JP; RESPOND CRT Investigators. Contractility sensor-guided optimization of cardiac resynchronization therapy: results from the RESPOND-CRT trial. Eur Heart J. 2017 Mar 7;38(10):730-738.